BioSpace News Archive

UCB, a global biopharmaceutical company, today announced that Annals of the Rheumatic Diseases has published 24-week results from the Phase 3 BE MOBILE 1 and BE MOBILE 2 studies.

EVOQ Therapeutics today announced the advancement of their ongoing license and collaboration agreement with Amgen for the discovery and development of novel therapeutics including the receipt of a milestone payment and expansion of the scope of collaboration to include a total of three indications in autoimmune disorders.

OpGen, Inc. today announced preliminary unaudited revenue for 2022.

SciSparc Ltd. today announced it has been granted an approval by the Soroka University Medical Center (“Soroka Medical Center”) to conduct its clinical study for SCI-210 in patients suffering from autism spectrum disorder (“ASD”).

IntraOp Medical Corporation announced today that doctors at Vanderbilt University Medical Center (VUMC) treated a pancreatic cancer patient using IntraOp® Mobetron® Intra-Operative Radiation Therapy (IORT).

The efficacy of Novarad’s VisAR Augmented Reality Guidance system demonstrated an angular error of 1.3° (close to what can be achieved with a robot and below the 2° standard for stereotactic cranial navigation set by the FDA in a recent published article in the peer reviewed journal Neurosurgery for simulated external ventricular drain (EVD) placement.

Changing Patient Care Through Innovation Nihon Kohden America, Inc., a U.S. market leader in precision medical products and services, is happy to introduce CoMET, a tool that can provide an early indication of future risk of catastrophic clinical events.

Ascentage Pharma and Innovent Biologics, Inc., announced that the novel drug olverembatinib has been included into the China 2022 National Reimbursement Drug List（NRDL), for the treatment of T315I-mutant chronic-phase chronic myeloid leukemia and accelerated-phase CML.

Kaneka Corporation has decided to increase its GMP*1 manufacturing capacity for mRNA*2 in Kaneka Eurogentec S.A., a wholly owned group company in Europe.

The vagus nerve runs from the human brainstem to major peripheral organs and acts as the main conduit for the body’s inflammatory immune response to disease, bacteria and viruses.